Erin Quirk - President, Head of R&D at Terns Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President, Head of R&D
Stock Symbol
TERN on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Erin Quirk since 9/17/2023

Holdings reported by Erin Quirk for Terns Pharmaceuticals, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 75K $284K $3.78 Jan 23, 2024 Direct
Stock Option (Right to Buy) 150K Jan 23, 2024 Direct Common Stock

Transactions reported by Erin Quirk for Terns Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.